Year |
Citation |
Score |
2004 |
Capiaux GM, Budak-Alpdogan T, Alpdogan O, Bornmann W, Takebe N, Banerjee D, Maley F, Bertino JR. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene Cancer Gene Therapy. 11: 767-773. PMID 15359285 DOI: 10.1038/Sj.Cgt.7700683 |
0.58 |
|
2003 |
Capiaux GM, Budak-Alpdogan T, Takebe N, Mayer-Kuckuk P, Banerjee D, Maley F, Bertino JR. Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil. Human Gene Therapy. 14: 435-46. PMID 12691609 DOI: 10.1089/104303403321467207 |
0.563 |
|
2002 |
Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochimica Et Biophysica Acta. 1587: 164-73. PMID 12084458 |
0.533 |
|
2001 |
Sapse AM, Capiaux GM, Bertino JR. Examination of the reduced affinity of the thymidylate synthase G52S mutation for FdUMP by ab initio and semi-empirical studies. Molecular Medicine (Cambridge, Mass.). 7: 200-4. PMID 11471557 DOI: 10.1007/Bf03401954 |
0.421 |
|
1999 |
Banerjee D, Tong Y, Liu-Chen X, Capiaux G, Ercikan-Abali EA, Takebe N, O'Connor OA, Bertino JR. Protection of bone marrow cells from toxicity of chemotherapeutic agents targeted toward thymidylate synthase by transfer of mutant forms of human thymidylate synthase cDNA. Progress in Experimental Tumor Research. 36: 107-14. PMID 10386068 DOI: 10.1159/000061991 |
0.425 |
|
1998 |
Tong Y, Liu-Chen X, Ercikan-Abali EA, Capiaux GM, Zhao SC, Banerjee D, Bertino JR. Isolation and characterization of thymitaq (AG337) and 5-fluoro-2-deoxyuridylate-resistant mutants of human thymidylate synthase from ethyl methanesulfonate-exposed human sarcoma HT1080 cells. The Journal of Biological Chemistry. 273: 11611-8. PMID 9565579 |
0.566 |
|
Show low-probability matches. |